Please login to the form below

inflammatory diseases

This page shows the latest inflammatory diseases news and features for those working in and with pharma, biotech and healthcare.

PureTech adds potential IBD therapeutic to pipeline after buying out Alivio Therapeutics

Alivio’s technology platform can combine a biologic agent and a small molecule drug into a single oral dosage form, potentially offering an enhanced treatment for certain inflammatory diseases by maximising ... treat inflammatory diseases,” she added.

Latest news

US Supreme Court rebuffs Sandoz’s Enbrel biosimilar patent case

Today’s decision means Erelzi, a more affordable biosimilar, will not be available to US patients with autoimmune and inflammatory diseases until 2029; nonetheless we remain committed to providing important treatment ... options for patients affected
Lilly signs $960m deal with Rigel to develop RIPK1 inhibitors

Lilly will co-develop and commercialise R552 across all indications, including autoimmune and inflammatory diseases. ... The ethos behind RIPK1 inhibitor development is to offer a new kind of approach towards treating a range of autoimmune, inflammatory
Horizon bolsters rare disease portfolio with $3bn Viela Bio acquisition

Viela is also evaluating Uplizna in phase 3 trails in the rare autoimmune neuromuscular disorder myasthenia gravis and in IgG4-related diseases. ... We believe that the combined pipeline, including the pursuit of additional potential indications, has the
Sanofi gains access to antibody tech with Kymab acquisition

treat a range of immune-mediated disorders and inflammatory diseases. ... The Kymab acquisition adds KY1005 to our dynamic pipeline, a potential first-in-class treatment for a range of immune and inflammatory diseases.
Novartis’ canakinumab failed to improve survival in COVID-19 study

Excessive production of IL-1β plays a significant role in certain inflammatory diseases and immune responses. ... Developers theorised that these drugs could have an impact on CRS, a form of systemic inflammatory response that can occur as a

More from news
Approximately 4 fully matching, plus 132 partially matching documents found.

Latest Intelligence

Switzerland: a life sciences hub

oral treatments to treat patients with inflammatory bowel diseases. ... The company has been using artificial intelligence for the past eight years to help detect certain diseases such as cancer.
20 for 2020 – Five pharma leaders to watch in 2020

In the meantime, Sanofi is stepping up its focus in other areas like immunological and inflammatory diseases, rare blood disorders and vaccines, as well as cancer – an area it had been ... Meanwhile, Galapagos looks set to continue adding to its
Innovation in merger control and the impact on the pharmaceutical sector

Specifically, Hospira was selling Inflectra, an infliximab biosimilar used to treat several chronic inflammatory diseases, notably the inflammation of Crohn’s disease, while Pfizer was in an advanced stage of developing
‘How is your day?’

Physicians need to be more aware of rare diseases that may hide behind recurring issues that some patients have. ... These are: Primary Immunodeficiency Diseases (PID – causes severe infections); Chronic Inflammatory Demyelinating Polyneuropathy (CIDP
The tipping point

In chronic diseases such as rheumatoid arthritis and inflammatory bowel disease, there are significantly greater savings from switching patients compared with initiating biosimilars in naïve patients alone.

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences

He has 30 years’ experience in research and development specifically in gastrointestinal disorders, inflammatory diseases and cancers, and previously co-founded Synergy Pharmaceuticals and served as its chief scientific officer.
Kymab appoints its first chief medical officer

She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.
Dr Li Zhou joins TxCell as cell engineering VP

Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ
Vedanta Biosciences appoints two new heads

Vedanta is advancing a pipeline of product candidates designed to treat autoimmune, inflammatory and infectious diseases using technology that mines the human microbiome for potent pharmaceutical products.
Lorin Johnson joins Atlantic Healthcare board

Atlantic's lead asset, alicaforsen for the treatment of the inflammatory bowel diseases ulcerative colitis and pouchitis.

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

A magic milestone: Sally’s 10-year #LucidLife workiversary

room, to the impact you’ve made on people’s lives with inflammatory diseases.
Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic arthritis and akylosing spondylitis,

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Vaccines writer – career opportunity to move into medcomms from ...: Highly competitive salary

Client Services Director, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

B2B media account director: Competitive salary

HR Manager – Recruitment/ Generalist combined role, Marketing ag...: circa £50K

Senior Account Exec > CSD – Medical Communications – UK, Lond...: Highly Competitive Salary, Bonus &Benefits

Principal Medical Writer, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Medical Writers > Scientific Directors – Medical Communicatio...: Highly Competitive Salary, Bonus &Benefits

Scientific Director, MRNA/ Covid 19, Medical Communications, UK: Six figure salary

PMHub

Add my company

Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs: In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?: Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:: Securing a future for telehealth with immersive market research insights...

Email:
Password:

Please login to the form below

inflammatory diseases

COVID-19 Updates and Daily News

Featured jobs

Quick links